ArticleCurrent microbiology2025
High Yield of Prodigiosin by Serratia marcescens Ka3 Using Additive Huangshui, a Byproduct of Chinese Liquor (Baijiu).
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Breeding ofBiodesign research · 2026Article
- Optimization of Solid-State Fermentation Process for Prodigiosin Production from Soybean Residue UsingMicroorganisms · 2026Article
- Prodigiosin Enhanced TMZ Chemosensitivity by Suppressing Focal Adhesion and Inhibiting Autophagy in Glioblastoma Cells.Biomolecules · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Huangshui, a characteristic byproduct of Chinese liquor production, was first used as an additive to promote the production of prodigiosin with Serratia marcescens Ka3 in a 5 L bioreactor. Based on the prodigiosin levels in the peptone glycerol medium, the yield of prodigiosin reached 48,341 mg/L after adding 1% Huangshui following 60 h of fermentation, which is currently a high yield in bioreactors. The purity of the prodigiosin extracted from the fermentation broth and purified using a microporous filter membrane was 97%. Purified prodigiosin showed significant inhibitory effects on human lung carcinoma A549 cells and human colon adenocarcinoma HT29 cells. It also inhibited the human gastric adenocarcinoma SGC7901 cells, albeit not significantly. The IC
Indexed as
Identifiers
40314753What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.